Wolverine Blend
BPC-157: A synthetic fragment of Body Protection Compound, a peptide found in gastric juice.
Known for its healing, anti-inflammatory, and angiogenic properties.
Works mainly by promoting blood vessel growth, regulating growth factors, and accelerating soft tissue repair.
TB-500 (Thymosin Beta-4 fragment): A synthetic version of a short chain of the Thymosin Beta-4 protein.
Plays a role in cell migration, tissue regeneration, and wound healing.
Especially active in actin regulation, which is critical for cellular movement and repair.
BPC-157:
Stimulates angiogenesis (new blood vessel formation).
Regulates nitric oxide → improves blood flow and circulation.
Protects the GI tract and accelerates tendon/ligament repair.
Reduces inflammatory cytokines.
TB-500:
Increases cell migration & differentiation to injury sites.
Promotes angiogenesis & wound closure.
Reduces inflammation & fibrosis in tissues.
Plays a role in heart, eye, and skin repair (preclinical data).
Faster healing of tendons, ligaments, and muscles.
Support in joint injuries and arthritis.
Reduced inflammation in both acute and chronic injuries.
Potential organ protection (liver, gut, heart, brain—mostly preclinical).
Synergy when combined:
BPC-157 improves circulation and reduces inflammation.
TB-500 drives cellular migration and repair.
Together, they may accelerate recovery and tissue integrity more than either alone.
Generally well tolerated in anecdotal and preclinical reports.
Mild: redness at injection site, headache, fatigue.
Unknown: Long-term safety in humans has not been studied.
⚠️ Neither is FDA-approved → use remains experimental.
BPC-157 = angiogenesis + anti-inflammatory + gut protection.
TB-500 = cell migration + tissue regeneration + wound healing.
Combined use: complementary actions may speed recovery, especially for sports injuries, tendon/ligament healing, and chronic inflammation.
Status: Experimental; human trials limited, most evidence from animal models and anecdotal clinic reports.
Wolverine Blend
BPC-157: A synthetic fragment of Body Protection Compound, a peptide found in gastric juice.
Known for its healing, anti-inflammatory, and angiogenic properties.
Works mainly by promoting blood vessel growth, regulating growth factors, and accelerating soft tissue repair.
TB-500 (Thymosin Beta-4 fragment): A synthetic version of a short chain of the Thymosin Beta-4 protein.
Plays a role in cell migration, tissue regeneration, and wound healing.
Especially active in actin regulation, which is critical for cellular movement and repair.
BPC-157:
Stimulates angiogenesis (new blood vessel formation).
Regulates nitric oxide → improves blood flow and circulation.
Protects the GI tract and accelerates tendon/ligament repair.
Reduces inflammatory cytokines.
TB-500:
Increases cell migration & differentiation to injury sites.
Promotes angiogenesis & wound closure.
Reduces inflammation & fibrosis in tissues.
Plays a role in heart, eye, and skin repair (preclinical data).
Faster healing of tendons, ligaments, and muscles.
Support in joint injuries and arthritis.
Reduced inflammation in both acute and chronic injuries.
Potential organ protection (liver, gut, heart, brain—mostly preclinical).
Synergy when combined:
BPC-157 improves circulation and reduces inflammation.
TB-500 drives cellular migration and repair.
Together, they may accelerate recovery and tissue integrity more than either alone.
Generally well tolerated in anecdotal and preclinical reports.
Mild: redness at injection site, headache, fatigue.
Unknown: Long-term safety in humans has not been studied.
⚠️ Neither is FDA-approved → use remains experimental.
BPC-157 = angiogenesis + anti-inflammatory + gut protection.
TB-500 = cell migration + tissue regeneration + wound healing.
Combined use: complementary actions may speed recovery, especially for sports injuries, tendon/ligament healing, and chronic inflammation.
Status: Experimental; human trials limited, most evidence from animal models and anecdotal clinic reports.
